Article
Dihydroartemisinin downregulates the expression of COX-2 in esophageal squamous cell carcinoma through ROS/MAPK/Sp1 axis
2025-11-10
Abstract excerpt
<title>Abstract</title> <p>Background Esophageal squamous cell carcinoma (ESCC) is associated with a poor clinical prognosis due to its highly invasive and metastatic characteristics, as well as chemotherapy resistance, highlighting an urgent need to explore novel therapeutic targets and drugs. Dihydroartemisinin (DHA), a derivative of artemisinin, has been demonstrated to possess broad anti-tumor activity, while...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a5f7343d-969f-5d32-91f9-4ac48dace85d
- DOI
- 10.21203/rs.3.rs-7882728/v1
